Open AccessCombined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen
Author(s) -
Barbara Simón,
Andrea Ceglédi,
János Dolgos,
Péter Farkas,
Manila Gaddh,
László Hankó,
Róbert Horváth,
Ambrus Kaposi,
Lászlóné Magyar,
Tamás Masszi,
Attila Szederjesi,
Nikolett Wohner,
Imre Bodó
Publication year - 2022
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2022016873
Subject(s) - medicine , regimen , interquartile range , toxicity , immunosuppression , cyclophosphamide , rituximab , gastroenterology , surgery , dexamethasone , neutropenia , chemotherapy , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom